Annual accounts & ratios
Source: NBB · 2024How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil–Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 73.5% | 8.8% | |
| Net result | €9.26M | €-3k | |
| Equity | €54.40M | €56k | |
| Gross operating margin | €745k | €28k | |
| Staff costs | €245k | €40k |
| Fiscal year | 2024 |
|---|---|
| Revenue | — |
| EBITDA | €414k |
| Net profit | €9.26M |
| Cash flow | €9.72M |
| Staff costs | €245k |
| Income taxes | €1.27M |
| Dividends | €4.62M |
| Total assets | €73.99M |
| Equity | €54.40M |
| Debt | €19.57M |
| of which ≤ 1y | €13.15M |
| of which > 1y | €6.23M |
| Working capital | €38.81M |
| Employees (FTE) | 2.3 |
| 2024 | |
|---|---|
| Current ratio | 3.95 |
| Quick ratio | 3.95 |
| Working capital ratio | 52.5% |
| Solvency | 73.5% |
| Debt / equity | 0.36 |
| Long-term debt ratio | 0.11 |
| Interest coverage | 1.30 |
| Gross margin | — |
| Net margin | — |
| ROA | 12.5% |
| ROE | 17.0% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €73.99M |
| Fixed assets | 21/28 | €22.03M |
| Tangible fixed assets | 22/27 | €18.47M |
| Financial fixed assets | 28 | €3.56M |
| Current assets | 29/58 | €51.96M |
| Stocks & contracts in progress | 3 | €18k |
| Amounts receivable within one year | 40/41 | €25.51M |
| Investments | 50/53 | €24.83M |
| Cash & bank | 54/58 | €1.50M |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €73.99M |
| Equity | 10/15 | €54.40M |
| Contributions / capital | 10/11 | €3.82M |
| Reserves | 13 | €38.50M |
| Accumulated profits (losses) | 14 | €12.08M |
| Provisions & deferred taxes | 16 | €20k |
| Amounts payable | 17/49 | €19.57M |
| Amounts payable after one year | 17 | €6.23M |
| Amounts payable within one year | 42/48 | €13.15M |
| Trade debts payable within one year | 44 | €82k |
| Income statement | ||
| Gross operating margin | 9900 | €745k |
| Operating result | 9901 | €-47k |
| Financial income | 75 | €10.89M |
| Financial charges | 65 | €319k |
| Result before taxes | 9903 | €10.53M |
| Income taxes | 67/77 | €1.27M |
| Net result for the period | 9904 | €9.26M |
| Result to be appropriated | 9905 | €9.27M |
Health barometer
FY 2024 · computedUnlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →